Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hair Color
|
312 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.800 | 1.000 | 3 | 2008 | 2013 | |||||
Eye Color
|
31 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.800 | 1.000 | 2 | 2010 | 2018 | |||||
Progressive supranuclear palsy
|
52 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Squamous cell carcinoma
|
257 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.710 | 1.000 | 3 | 2011 | 2019 | |||||
Skin Pigmentation
|
72 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 3 | 2013 | 2018 | |||||
Suntan
|
94 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 3 | 2013 | 2018 | |||||
Alopecia, Androgenetic, 1
|
104 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Alopecia, Androgenetic, 2
|
104 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Alopecia, Androgenetic, 3
|
104 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Alopecia, Male Pattern
|
743 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Androgenetic Alopecia
|
107 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Basal Cell Cancer
|
109 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||
Basal cell carcinoma
|
109 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||
Basal Cell Neoplasm
|
109 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||
Melanosis
|
23 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2010 | 2018 | |||||
Other alopecia
|
104 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||
Alopecia
|
375 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||
Freckles
|
10 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Skin carcinoma
|
24 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Squamous cell carcinoma of skin
|
92 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Vitiligo
|
249 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
White Blood Cell Count procedure
|
1322 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Skin-Hair-Eye Pigmentation, Variation In, 8
|
1 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.700 | 0 | ||||||||
melanoma
|
515 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.060 | 1.000 | 6 | 2010 | 2017 | |||||
Carcinoma, Basal Cell
|
91 | 0.649 | 0.320 | 6 | 396321 | intron variant | C/T | snv | 0.10 | 0.030 | 1.000 | 3 | 2011 | 2019 |